GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procyon Corp (OTCPK:PCYN) » Definitions » Price-to-Owner-Earnings

PCYN (Procyon) Price-to-Owner-Earnings : (As of May. 12, 2025)


View and export this data going back to . Start your Free Trial

What is Procyon Price-to-Owner-Earnings?

As of today (2025-05-12), Procyon's share price is $0.18. Procyon does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Procyon's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Procyon was 280.00. The lowest was 3.00. And the median was 12.53.


PCYN's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.04
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-12), Procyon's share price is $0.18. Procyon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.04. Therefore, Procyon's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-12), Procyon's share price is $0.18. Procyon's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.04. Therefore, Procyon's PE Ratio without NRI for today is At Loss.

During the past 13 years, Procyon's highest PE Ratio without NRI was 280.00. The lowest was 0.00. And the median was 19.23.


Procyon Price-to-Owner-Earnings Historical Data

The historical data trend for Procyon's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procyon Price-to-Owner-Earnings Chart

Procyon Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.53 3.55 - 7.14 -

Procyon Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.14 5.60 15.50 16.55 -

Competitive Comparison of Procyon's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Procyon's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procyon's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procyon's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Procyon's Price-to-Owner-Earnings falls into.


;
;

Procyon Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Procyon's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.18/-0.02
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procyon  (OTCPK:PCYN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Procyon Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Procyon's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Procyon Business Description

Traded in Other Exchanges
N/A
Address
164 Douglas Road, Oldsmar, FL, USA, 34677
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
Executives
Foundation Speer 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Suggs Fred Wilson Jr director 60 FOREST LANE, GREENVILLE SC 29605
Steven Mccomas director 800 LASTAHOUSE DRIVE, VIDALIA GA 30474
Monica Mccullough director 1095 55TH TERR SO, SAINT PETERSBURG FL 33705
Joseph Raymond Treshler director PO BOX 5719, CLEARWATER FL 33758
George Otis Borak officer: Vice President 3300 COVE CAY DR, UNIT 7D, CLEARWATER FL 33760
Lynnda L Speer 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Richard M. Speer 10 percent owner 104 WOODMONT BOULEVARD, SUITE 415, NASHVILLE TN 37205
Speer Roy M Foundation 10 percent owner 2535 SUCCESS DRIVE, ODESSA FL 33556
Paul Edward Kudelko director 28 WINSTON DR, BELLEAIR FL 33756
Justice Wolfe Anderson director, officer: VP-Sales and Marketing 1300 S HIGHLAND AVE, CLEARWATER FL 33756
Regina Wolfe Anderson director 1300 S HIGHLAND AVE, CLEARWATER FL 33756
Jeffrey S Slowgrove director C/O INFORMATION MANAGEMENT RESOURCES INC, 26750 US HIGHWAY N #500, CLEARWATER FL 34621
John C Anderson Trust 10 percent owner 440 S GULFVIEW BLVD, APT 1702N, CLEARWATER FL 33767
Michael Timothy Foley director 2284 KINGS POINT DRIVE, LARGO FL 33774

Procyon Headlines

No Headlines